Alprazolam + Seratraline -(Aug 2006)
Drug Name:
Alprazolam + Seratraline -(Aug 2006)
List Of Brands:
Indication Type Description:
Indication:
Patent Expiry Date of drugs (Ref - IDMA Publication)
Chemical Category Manufacturer/ US Patent
Ingredient- Marketer Expiration Date
Alprozolam CNS Pharmacia & 16-09-2002
Upjohn
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Alprozolam Anxiolytic agent June 1988
2.Alprozolam dis tab 0.125mg/0.25mg/0.50mg 20-09- 2006
For anxiety
3.Alprozolam SR 0.25mg + Seratraline Hcl 25mg/50mg 09-08-2006
tablet
For Panic disorder with with or without agoraphobia
Anxiety
Dosages/ Overdosage Etc:
Approved by (DCI) Drug Controller GENERAL - India For Marketing (Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Alprozolam Anxiolytic agent June 1988
2.Alprozolam dis tab 0.125mg/0.25mg/0.50mg 20-09- 2006
For anxiety
3.Alprozolam SR 0.25mg + Seratraline Hcl 25mg/50mg 09-08-2006
tablet
For Panic disorder with with or without agoraphobia
Indication-
Anxiety adults
Dosage-
0.25 - 0.5 mg tid
Other Information:
For Availability/supplies
Contact -
1.Indian Drug Manufacturers Association (IDMA)
Phone- 022- 24944624/ 24974308
Fax- 022- 24950723
Email- idma@vsnl.com
Website: www.idma-assn.org
2.Bulk Drug Manufacturers Association (India)(BDMA)
Phone - 040-23703910/ 23706718
Fax- 040-23704804
Email- info@bdmai.org
Website: www.info@bdmai.org